Lv1
90 积分 2026-05-17 加入
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
1个月前
已完结
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
1个月前
已完结
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
1个月前
已完结
Breast Cancer Treatment
1个月前
已完结
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
1个月前
已完结
Triple-Negative Breast Cancer
1个月前
已完结
When mutants gain new powers: news from the mutant p53 field
3个月前
已完结
Shaping genetic alterations in human cancer: the p53 mutation paradigm
3个月前
已完结
Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer
3个月前
已完结
Peripheral Neutrophil to Lymphocyte Ratio (NLR), a cogent clinical adjunct for Ki-67 in breast cancer
3个月前
已完结
皖公网安备34019202002308
